Cas:62922-39-8 2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate manufacturer & supplier

Chemical Name:2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate

CAS.NO:62922-39-8

Synonyms:2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate

Molecular Formula:C₁₅H₁₉Cl₃O₄

Molecular Weight:369.66800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:44.76000

Exact Mass:368.03500

LogP:4.77400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate Use and application,2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate technical grade,usp/ep/jp grade.

Related News: In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining. 2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate manufacturer Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate supplier We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed. 2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate vendor Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. 2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate factory The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.